Coinspeaker

© 2025 Coinspeaker LTD. ALL RIGHTS RESERVED.

Home Organizations Healthcare Gilead Sciences Inc.
Gilead Sciences Inc.

Gilead Sciences Inc.

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

go to website

Gilead Sciences, Inc., is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Click to see more
Gilead Sciences Inc. Details
  • Operating Status: Active
  • Business Type Public
  • Headquarters Foster City, California, United States
  • Founded Date 1987
  • Organization CEO Daniel O’Day
  • Founders Michael L. Riordan
Gilead Sciences Inc. Chart

Gilead Sciences Inc. News
GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings
By October 29th, 2020
Business News, Market News, News GILD Stock Dips by 2.15%, Despite Reporting Profitable Q3 Earnings
By October 29th, 2020

Gilead Sciences Inc, the American biopharmaceutical company behind the only approved drug for the treatment of COVID-19 known as Remdesivir (or Veklury) has released its third-quarter earnings in which the company posted better than expected earnings. Per the figures posted, GILD reported product sales of $6.5 billion, an 18% increment year-over-year.